nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCC2—epilepsy syndrome	0.0939	0.379	CbGaD
Mycophenolate mofetil—ABCG2—epilepsy syndrome	0.083	0.335	CbGaD
Mycophenolate mofetil—UGT1A8—Propofol—epilepsy syndrome	0.0539	0.112	CbGbCtD
Mycophenolate mofetil—UGT1A6—Propofol—epilepsy syndrome	0.0466	0.0965	CbGbCtD
Mycophenolate mofetil—UGT1A10—Valproic Acid—epilepsy syndrome	0.0385	0.0798	CbGbCtD
Mycophenolate mofetil—UGT1A8—Valproic Acid—epilepsy syndrome	0.0385	0.0798	CbGbCtD
Mycophenolate mofetil—ALB—epilepsy syndrome	0.0362	0.146	CbGaD
Mycophenolate mofetil—ABCB1—epilepsy syndrome	0.0346	0.14	CbGaD
Mycophenolate mofetil—UGT1A6—Valproic Acid—epilepsy syndrome	0.0332	0.0689	CbGbCtD
Mycophenolate mofetil—CES1—Rufinamide—epilepsy syndrome	0.0274	0.0569	CbGbCtD
Mycophenolate mofetil—UGT2B7—Carbamazepine—epilepsy syndrome	0.0154	0.0318	CbGbCtD
Mycophenolate mofetil—ABCC2—Levetiracetam—epilepsy syndrome	0.0141	0.0292	CbGbCtD
Mycophenolate mofetil—UGT1A9—Propofol—epilepsy syndrome	0.0136	0.0281	CbGbCtD
Mycophenolate mofetil—UGT1A1—Propofol—epilepsy syndrome	0.0111	0.023	CbGbCtD
Mycophenolate mofetil—UGT1A9—Valproic Acid—epilepsy syndrome	0.0097	0.0201	CbGbCtD
Mycophenolate mofetil—UGT2B7—Valproic Acid—epilepsy syndrome	0.00917	0.019	CbGbCtD
Mycophenolate mofetil—ABCC2—Carbamazepine—epilepsy syndrome	0.00808	0.0167	CbGbCtD
Mycophenolate mofetil—ALB—Oxcarbazepine—epilepsy syndrome	0.00801	0.0166	CbGbCtD
Mycophenolate mofetil—ABCC2—Phenytoin—epilepsy syndrome	0.00724	0.015	CbGbCtD
Mycophenolate mofetil—ALB—Fosphenytoin—epilepsy syndrome	0.007	0.0145	CbGbCtD
Mycophenolate mofetil—ABCC2—Phenobarbital—epilepsy syndrome	0.00646	0.0134	CbGbCtD
Mycophenolate mofetil—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00644	0.0134	CbGbCtD
Mycophenolate mofetil—ALB—Clonazepam—epilepsy syndrome	0.00633	0.0131	CbGbCtD
Mycophenolate mofetil—CYP2C8—Trimethadione—epilepsy syndrome	0.00576	0.0119	CbGbCtD
Mycophenolate mofetil—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00541	0.0112	CbGbCtD
Mycophenolate mofetil—ALB—Rufinamide—epilepsy syndrome	0.00516	0.0107	CbGbCtD
Mycophenolate mofetil—ABCB1—Levetiracetam—epilepsy syndrome	0.00458	0.0095	CbGbCtD
Mycophenolate mofetil—ALB—Phenytoin—epilepsy syndrome	0.00451	0.00936	CbGbCtD
Mycophenolate mofetil—ALB—Propofol—epilepsy syndrome	0.00421	0.00873	CbGbCtD
Mycophenolate mofetil—CYP3A5—Carbamazepine—epilepsy syndrome	0.00404	0.00839	CbGbCtD
Mycophenolate mofetil—CYP2C8—Carbamazepine—epilepsy syndrome	0.00389	0.00806	CbGbCtD
Mycophenolate mofetil—ALB—Diazepam—epilepsy syndrome	0.00381	0.00791	CbGbCtD
Mycophenolate mofetil—CYP2C8—Primidone—epilepsy syndrome	0.00363	0.00753	CbGbCtD
Mycophenolate mofetil—CYP3A5—Phenytoin—epilepsy syndrome	0.00363	0.00752	CbGbCtD
Mycophenolate mofetil—CYP2C8—Phenytoin—epilepsy syndrome	0.00349	0.00723	CbGbCtD
Mycophenolate mofetil—CYP2C8—Propofol—epilepsy syndrome	0.00325	0.00675	CbGbCtD
Mycophenolate mofetil—CYP3A5—Phenobarbital—epilepsy syndrome	0.00323	0.0067	CbGbCtD
Mycophenolate mofetil—CYP3A5—Midazolam—epilepsy syndrome	0.00319	0.00661	CbGbCtD
Mycophenolate mofetil—ABCB1—Clobazam—epilepsy syndrome	0.00318	0.00659	CbGbCtD
Mycophenolate mofetil—CYP2C8—Phenobarbital—epilepsy syndrome	0.00311	0.00645	CbGbCtD
Mycophenolate mofetil—CYP3A5—Diazepam—epilepsy syndrome	0.00307	0.00636	CbGbCtD
Mycophenolate mofetil—ABCB1—Lamotrigine—epilepsy syndrome	0.00306	0.00634	CbGbCtD
Mycophenolate mofetil—CYP2C8—Diazepam—epilepsy syndrome	0.00295	0.00611	CbGbCtD
Mycophenolate mofetil—ABCB1—Carbamazepine—epilepsy syndrome	0.00263	0.00546	CbGbCtD
Mycophenolate mofetil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00251	0.00521	CbGbCtD
Mycophenolate mofetil—CYP3A5—Valproic Acid—epilepsy syndrome	0.00242	0.00501	CbGbCtD
Mycophenolate mofetil—ABCB1—Phenytoin—epilepsy syndrome	0.00236	0.0049	CbGbCtD
Mycophenolate mofetil—CYP3A4—Trimethadione—epilepsy syndrome	0.00233	0.00484	CbGbCtD
Mycophenolate mofetil—CYP3A4—Felbamate—epilepsy syndrome	0.00233	0.00484	CbGbCtD
Mycophenolate mofetil—CYP2C8—Valproic Acid—epilepsy syndrome	0.00232	0.00482	CbGbCtD
Mycophenolate mofetil—UGT1A8—tongue—epilepsy syndrome	0.00222	0.168	CbGeAlD
Mycophenolate mofetil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0022	0.00455	CbGbCtD
Mycophenolate mofetil—ABCB1—Phenobarbital—epilepsy syndrome	0.0021	0.00436	CbGbCtD
Mycophenolate mofetil—ABCB1—Midazolam—epilepsy syndrome	0.00208	0.0043	CbGbCtD
Mycophenolate mofetil—ABCB1—Diazepam—epilepsy syndrome	0.002	0.00414	CbGbCtD
Mycophenolate mofetil—CYP3A4—Clonazepam—epilepsy syndrome	0.00199	0.00412	CbGbCtD
Mycophenolate mofetil—CYP3A4—Clobazam—epilepsy syndrome	0.0019	0.00395	CbGbCtD
Mycophenolate mofetil—CYP3A4—Rufinamide—epilepsy syndrome	0.00162	0.00336	CbGbCtD
Mycophenolate mofetil—CYP3A4—Carbamazepine—epilepsy syndrome	0.00158	0.00327	CbGbCtD
Mycophenolate mofetil—CYP3A4—Primidone—epilepsy syndrome	0.00147	0.00305	CbGbCtD
Mycophenolate mofetil—CYP3A4—Phenytoin—epilepsy syndrome	0.00141	0.00293	CbGbCtD
Mycophenolate mofetil—CYP3A4—Propofol—epilepsy syndrome	0.00132	0.00274	CbGbCtD
Mycophenolate mofetil—CYP3A4—Phenobarbital—epilepsy syndrome	0.00126	0.00261	CbGbCtD
Mycophenolate mofetil—CYP3A4—Acetazolamide—epilepsy syndrome	0.00126	0.00261	CbGbCtD
Mycophenolate mofetil—CYP3A4—Midazolam—epilepsy syndrome	0.00124	0.00258	CbGbCtD
Mycophenolate mofetil—IMPDH2—Bortezomib—Lacosamide—epilepsy syndrome	0.00124	1	CbGdCrCtD
Mycophenolate mofetil—CYP3A4—Diazepam—epilepsy syndrome	0.0012	0.00248	CbGbCtD
Mycophenolate mofetil—CYP3A4—Zonisamide—epilepsy syndrome	0.00117	0.00242	CbGbCtD
Mycophenolate mofetil—CYP3A4—Valproic Acid—epilepsy syndrome	0.000942	0.00195	CbGbCtD
Mycophenolate mofetil—CYP3A4—Topiramate—epilepsy syndrome	0.00085	0.00176	CbGbCtD
Mycophenolate mofetil—UGT1A8—head—epilepsy syndrome	0.000538	0.0407	CbGeAlD
Mycophenolate mofetil—IMPDH2—telencephalon—epilepsy syndrome	0.000487	0.0368	CbGeAlD
Mycophenolate mofetil—CES2—telencephalon—epilepsy syndrome	0.000442	0.0335	CbGeAlD
Mycophenolate mofetil—IMPDH2—medulla oblongata—epilepsy syndrome	0.000383	0.0289	CbGeAlD
Mycophenolate mofetil—IMPDH1—medulla oblongata—epilepsy syndrome	0.00038	0.0288	CbGeAlD
Mycophenolate mofetil—IMPDH2—midbrain—epilepsy syndrome	0.00035	0.0264	CbGeAlD
Mycophenolate mofetil—CES2—medulla oblongata—epilepsy syndrome	0.000348	0.0263	CbGeAlD
Mycophenolate mofetil—IMPDH1—midbrain—epilepsy syndrome	0.000347	0.0263	CbGeAlD
Mycophenolate mofetil—IMPDH2—spinal cord—epilepsy syndrome	0.000341	0.0258	CbGeAlD
Mycophenolate mofetil—IMPDH1—spinal cord—epilepsy syndrome	0.000339	0.0256	CbGeAlD
Mycophenolate mofetil—CES2—midbrain—epilepsy syndrome	0.000318	0.024	CbGeAlD
Mycophenolate mofetil—CES2—spinal cord—epilepsy syndrome	0.00031	0.0234	CbGeAlD
Mycophenolate mofetil—IMPDH2—head—epilepsy syndrome	0.000303	0.0229	CbGeAlD
Mycophenolate mofetil—IMPDH1—head—epilepsy syndrome	0.000301	0.0228	CbGeAlD
Mycophenolate mofetil—IMPDH2—nervous system—epilepsy syndrome	0.000287	0.0217	CbGeAlD
Mycophenolate mofetil—IMPDH1—nervous system—epilepsy syndrome	0.000286	0.0216	CbGeAlD
Mycophenolate mofetil—IMPDH2—central nervous system—epilepsy syndrome	0.000277	0.0209	CbGeAlD
Mycophenolate mofetil—CES2—head—epilepsy syndrome	0.000276	0.0208	CbGeAlD
Mycophenolate mofetil—IMPDH1—central nervous system—epilepsy syndrome	0.000275	0.0208	CbGeAlD
Mycophenolate mofetil—IMPDH2—cerebellum—epilepsy syndrome	0.00027	0.0205	CbGeAlD
Mycophenolate mofetil—IMPDH1—cerebellum—epilepsy syndrome	0.000269	0.0203	CbGeAlD
Mycophenolate mofetil—CES2—nervous system—epilepsy syndrome	0.000261	0.0198	CbGeAlD
Mycophenolate mofetil—CES2—central nervous system—epilepsy syndrome	0.000251	0.019	CbGeAlD
Mycophenolate mofetil—CES2—cerebellum—epilepsy syndrome	0.000246	0.0186	CbGeAlD
Mycophenolate mofetil—CES1—head—epilepsy syndrome	0.000227	0.0172	CbGeAlD
Mycophenolate mofetil—IMPDH2—brain—epilepsy syndrome	0.00022	0.0166	CbGeAlD
Mycophenolate mofetil—IMPDH1—brain—epilepsy syndrome	0.000218	0.0165	CbGeAlD
Mycophenolate mofetil—CES1—nervous system—epilepsy syndrome	0.000215	0.0163	CbGeAlD
Mycophenolate mofetil—CES1—central nervous system—epilepsy syndrome	0.000207	0.0157	CbGeAlD
Mycophenolate mofetil—CES2—brain—epilepsy syndrome	0.0002	0.0151	CbGeAlD
Mycophenolate mofetil—ABCG2—telencephalon—epilepsy syndrome	0.000173	0.0131	CbGeAlD
Mycophenolate mofetil—CES1—brain—epilepsy syndrome	0.000164	0.0124	CbGeAlD
Mycophenolate mofetil—ABCG2—medulla oblongata—epilepsy syndrome	0.000136	0.0103	CbGeAlD
Mycophenolate mofetil—ABCG2—midbrain—epilepsy syndrome	0.000124	0.0094	CbGeAlD
Mycophenolate mofetil—ABCG2—spinal cord—epilepsy syndrome	0.000121	0.00917	CbGeAlD
Mycophenolate mofetil—ALB—brain—epilepsy syndrome	0.000114	0.00865	CbGeAlD
Mycophenolate mofetil—ABCG2—cerebellum—epilepsy syndrome	9.62e-05	0.00727	CbGeAlD
Mycophenolate mofetil—ABCB1—forebrain—epilepsy syndrome	9.28e-05	0.00702	CbGeAlD
Mycophenolate mofetil—ABCB1—telencephalon—epilepsy syndrome	8.53e-05	0.00646	CbGeAlD
Mycophenolate mofetil—CYP2C8—brain—epilepsy syndrome	8.03e-05	0.00608	CbGeAlD
Mycophenolate mofetil—ABCG2—brain—epilepsy syndrome	7.81e-05	0.00591	CbGeAlD
Mycophenolate mofetil—CYP3A4—nervous system—epilepsy syndrome	7.12e-05	0.00538	CbGeAlD
Mycophenolate mofetil—CYP3A4—central nervous system—epilepsy syndrome	6.85e-05	0.00518	CbGeAlD
Mycophenolate mofetil—ABCB1—medulla oblongata—epilepsy syndrome	6.71e-05	0.00507	CbGeAlD
Mycophenolate mofetil—ABCB1—midbrain—epilepsy syndrome	6.13e-05	0.00464	CbGeAlD
Mycophenolate mofetil—ABCB1—spinal cord—epilepsy syndrome	5.98e-05	0.00452	CbGeAlD
Mycophenolate mofetil—ABCB1—head—epilepsy syndrome	5.31e-05	0.00402	CbGeAlD
Mycophenolate mofetil—ABCB1—nervous system—epilepsy syndrome	5.04e-05	0.00381	CbGeAlD
Mycophenolate mofetil—ABCB1—central nervous system—epilepsy syndrome	4.85e-05	0.00367	CbGeAlD
Mycophenolate mofetil—ABCB1—cerebellum—epilepsy syndrome	4.74e-05	0.00359	CbGeAlD
Mycophenolate mofetil—ABCB1—brain—epilepsy syndrome	3.85e-05	0.00291	CbGeAlD
Mycophenolate mofetil—Chest pain—Pregabalin—epilepsy syndrome	1.43e-05	8.2e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.43e-05	8.19e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Zonisamide—epilepsy syndrome	1.43e-05	8.19e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Diazepam—epilepsy syndrome	1.43e-05	8.19e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Pregabalin—epilepsy syndrome	1.43e-05	8.17e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Clonazepam—epilepsy syndrome	1.43e-05	8.17e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Gabapentin—epilepsy syndrome	1.42e-05	8.16e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.42e-05	8.14e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Valproic Acid—epilepsy syndrome	1.42e-05	8.12e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Carbamazepine—epilepsy syndrome	1.42e-05	8.12e-05	CcSEcCtD
Mycophenolate mofetil—Agitation—Gabapentin—epilepsy syndrome	1.42e-05	8.11e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Phenytoin—epilepsy syndrome	1.42e-05	8.11e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Pregabalin—epilepsy syndrome	1.41e-05	8.1e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Fosphenytoin—epilepsy syndrome	1.41e-05	8.09e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.41e-05	8.07e-05	CcSEcCtD
Mycophenolate mofetil—Angioedema—Gabapentin—epilepsy syndrome	1.41e-05	8.07e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.41e-05	8.06e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Felbamate—epilepsy syndrome	1.4e-05	8.04e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Pregabalin—epilepsy syndrome	1.4e-05	8.02e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Carbamazepine—epilepsy syndrome	1.4e-05	8.01e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Felbamate—epilepsy syndrome	1.39e-05	7.98e-05	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Topiramate—epilepsy syndrome	1.39e-05	7.97e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Felbamate—epilepsy syndrome	1.39e-05	7.97e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Gabapentin—epilepsy syndrome	1.39e-05	7.96e-05	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Topiramate—epilepsy syndrome	1.39e-05	7.95e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Gabapentin—epilepsy syndrome	1.38e-05	7.93e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Felbamate—epilepsy syndrome	1.38e-05	7.93e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Pregabalin—epilepsy syndrome	1.38e-05	7.92e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.38e-05	7.92e-05	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Topiramate—epilepsy syndrome	1.38e-05	7.92e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Gabapentin—epilepsy syndrome	1.38e-05	7.92e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Gabapentin—epilepsy syndrome	1.38e-05	7.9e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Clonazepam—epilepsy syndrome	1.38e-05	7.89e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Vigabatrin—epilepsy syndrome	1.38e-05	7.89e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Zonisamide—epilepsy syndrome	1.37e-05	7.87e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Valproic Acid—epilepsy syndrome	1.37e-05	7.86e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Pregabalin—epilepsy syndrome	1.37e-05	7.86e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.37e-05	7.86e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Lamotrigine—epilepsy syndrome	1.37e-05	7.85e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Phenytoin—epilepsy syndrome	1.37e-05	7.84e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Zonisamide—epilepsy syndrome	1.36e-05	7.81e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Pregabalin—epilepsy syndrome	1.36e-05	7.81e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Valproic Acid—epilepsy syndrome	1.36e-05	7.8e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Gabapentin—epilepsy syndrome	1.36e-05	7.8e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Zonisamide—epilepsy syndrome	1.36e-05	7.8e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Oxcarbazepine—epilepsy syndrome	1.36e-05	7.8e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Diazepam—epilepsy syndrome	1.36e-05	7.76e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Gabapentin—epilepsy syndrome	1.35e-05	7.76e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Zonisamide—epilepsy syndrome	1.35e-05	7.76e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Valproic Acid—epilepsy syndrome	1.35e-05	7.75e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Carbamazepine—epilepsy syndrome	1.35e-05	7.74e-05	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Topiramate—epilepsy syndrome	1.35e-05	7.74e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Lamotrigine—epilepsy syndrome	1.35e-05	7.74e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Pregabalin—epilepsy syndrome	1.35e-05	7.73e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Valproic Acid—epilepsy syndrome	1.35e-05	7.73e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Pregabalin—epilepsy syndrome	1.34e-05	7.71e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Gabapentin—epilepsy syndrome	1.34e-05	7.7e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.34e-05	7.69e-05	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Topiramate—epilepsy syndrome	1.34e-05	7.69e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Pregabalin—epilepsy syndrome	1.34e-05	7.67e-05	CcSEcCtD
Mycophenolate mofetil—Chills—Topiramate—epilepsy syndrome	1.34e-05	7.66e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Valproic Acid—epilepsy syndrome	1.34e-05	7.65e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Gabapentin—epilepsy syndrome	1.33e-05	7.65e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Pregabalin—epilepsy syndrome	1.33e-05	7.63e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Gabapentin—epilepsy syndrome	1.33e-05	7.62e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.33e-05	7.6e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Clonazepam—epilepsy syndrome	1.32e-05	7.59e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Valproic Acid—epilepsy syndrome	1.32e-05	7.56e-05	CcSEcCtD
Mycophenolate mofetil—Alopecia—Topiramate—epilepsy syndrome	1.32e-05	7.54e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Phenytoin—epilepsy syndrome	1.32e-05	7.54e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Clonazepam—epilepsy syndrome	1.31e-05	7.53e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Clonazepam—epilepsy syndrome	1.31e-05	7.52e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Gabapentin—epilepsy syndrome	1.31e-05	7.52e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Gabapentin—epilepsy syndrome	1.31e-05	7.52e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Gabapentin—epilepsy syndrome	1.31e-05	7.52e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Felbamate—epilepsy syndrome	1.31e-05	7.52e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.31e-05	7.5e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Oxcarbazepine—epilepsy syndrome	1.31e-05	7.5e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Gabapentin—epilepsy syndrome	1.31e-05	7.49e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Pregabalin—epilepsy syndrome	1.31e-05	7.49e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Carbamazepine—epilepsy syndrome	1.31e-05	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Lamotrigine—epilepsy syndrome	1.31e-05	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Clonazepam—epilepsy syndrome	1.3e-05	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Phenytoin—epilepsy syndrome	1.3e-05	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Topiramate—epilepsy syndrome	1.3e-05	7.47e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Phenytoin—epilepsy syndrome	1.3e-05	7.47e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.3e-05	7.46e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Oxcarbazepine—epilepsy syndrome	1.3e-05	7.44e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Valproic Acid—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Valproic Acid—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Phenytoin—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Topiramate—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Gabapentin—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Oxcarbazepine—epilepsy syndrome	1.29e-05	7.39e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Zonisamide—epilepsy syndrome	1.28e-05	7.36e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Gabapentin—epilepsy syndrome	1.28e-05	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Pregabalin—epilepsy syndrome	1.28e-05	7.34e-05	CcSEcCtD
Mycophenolate mofetil—Flatulence—Topiramate—epilepsy syndrome	1.28e-05	7.32e-05	CcSEcCtD
Mycophenolate mofetil—Tension—Topiramate—epilepsy syndrome	1.27e-05	7.29e-05	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Topiramate—epilepsy syndrome	1.27e-05	7.27e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Gabapentin—epilepsy syndrome	1.27e-05	7.26e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Lamotrigine—epilepsy syndrome	1.26e-05	7.23e-05	CcSEcCtD
Mycophenolate mofetil—Nervousness—Topiramate—epilepsy syndrome	1.26e-05	7.21e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.26e-05	7.2e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Gabapentin—epilepsy syndrome	1.26e-05	7.2e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Carbamazepine—epilepsy syndrome	1.26e-05	7.2e-05	CcSEcCtD
Mycophenolate mofetil—Back pain—Topiramate—epilepsy syndrome	1.25e-05	7.18e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.25e-05	7.16e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.25e-05	7.16e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Gabapentin—epilepsy syndrome	1.25e-05	7.16e-05	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Topiramate—epilepsy syndrome	1.25e-05	7.14e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Carbamazepine—epilepsy syndrome	1.25e-05	7.14e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Carbamazepine—epilepsy syndrome	1.24e-05	7.13e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.24e-05	7.11e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Pregabalin—epilepsy syndrome	1.24e-05	7.11e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Clonazepam—epilepsy syndrome	1.24e-05	7.09e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Carbamazepine—epilepsy syndrome	1.24e-05	7.09e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Gabapentin—epilepsy syndrome	1.24e-05	7.09e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Gabapentin—epilepsy syndrome	1.23e-05	7.07e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Pregabalin—epilepsy syndrome	1.23e-05	7.06e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.23e-05	7.05e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Phenytoin—epilepsy syndrome	1.23e-05	7.04e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Gabapentin—epilepsy syndrome	1.23e-05	7.03e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Pregabalin—epilepsy syndrome	1.22e-05	7.01e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Oxcarbazepine—epilepsy syndrome	1.22e-05	7e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Gabapentin—epilepsy syndrome	1.22e-05	7e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Pregabalin—epilepsy syndrome	1.22e-05	6.99e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.22e-05	6.97e-05	CcSEcCtD
Mycophenolate mofetil—Tremor—Topiramate—epilepsy syndrome	1.21e-05	6.96e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Lamotrigine—epilepsy syndrome	1.21e-05	6.95e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Valproic Acid—epilepsy syndrome	1.2e-05	6.9e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Lamotrigine—epilepsy syndrome	1.2e-05	6.9e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Topiramate—epilepsy syndrome	1.2e-05	6.89e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Lamotrigine—epilepsy syndrome	1.2e-05	6.89e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Valproic Acid—epilepsy syndrome	1.2e-05	6.87e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Valproic Acid—epilepsy syndrome	1.2e-05	6.87e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Gabapentin—epilepsy syndrome	1.2e-05	6.87e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Topiramate—epilepsy syndrome	1.2e-05	6.86e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Lamotrigine—epilepsy syndrome	1.2e-05	6.85e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Pregabalin—epilepsy syndrome	1.19e-05	6.83e-05	CcSEcCtD
Mycophenolate mofetil—Agitation—Topiramate—epilepsy syndrome	1.19e-05	6.83e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.18e-05	6.78e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Gabapentin—epilepsy syndrome	1.17e-05	6.73e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Carbamazepine—epilepsy syndrome	1.17e-05	6.72e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Pregabalin—epilepsy syndrome	1.17e-05	6.72e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Pregabalin—epilepsy syndrome	1.17e-05	6.72e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Topiramate—epilepsy syndrome	1.17e-05	6.7e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Topiramate—epilepsy syndrome	1.16e-05	6.67e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Topiramate—epilepsy syndrome	1.16e-05	6.66e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Topiramate—epilepsy syndrome	1.16e-05	6.65e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.15e-05	6.56e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Topiramate—epilepsy syndrome	1.15e-05	6.56e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Topiramate—epilepsy syndrome	1.14e-05	6.53e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Gabapentin—epilepsy syndrome	1.14e-05	6.52e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Lamotrigine—epilepsy syndrome	1.13e-05	6.5e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Topiramate—epilepsy syndrome	1.13e-05	6.48e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Pregabalin—epilepsy syndrome	1.13e-05	6.47e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Gabapentin—epilepsy syndrome	1.13e-05	6.47e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Topiramate—epilepsy syndrome	1.12e-05	6.44e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.12e-05	6.43e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Gabapentin—epilepsy syndrome	1.12e-05	6.42e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Topiramate—epilepsy syndrome	1.12e-05	6.41e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Gabapentin—epilepsy syndrome	1.12e-05	6.41e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.12e-05	6.4e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Gabapentin—epilepsy syndrome	1.11e-05	6.34e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Topiramate—epilepsy syndrome	1.1e-05	6.32e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Topiramate—epilepsy syndrome	1.1e-05	6.32e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Topiramate—epilepsy syndrome	1.1e-05	6.32e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Topiramate—epilepsy syndrome	1.1e-05	6.3e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.1e-05	6.28e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Gabapentin—epilepsy syndrome	1.09e-05	6.26e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Topiramate—epilepsy syndrome	1.09e-05	6.25e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Pregabalin—epilepsy syndrome	1.09e-05	6.24e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Valproic Acid—epilepsy syndrome	1.09e-05	6.24e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.09e-05	6.22e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Pregabalin—epilepsy syndrome	1.08e-05	6.21e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Pregabalin—epilepsy syndrome	1.08e-05	6.21e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Topiramate—epilepsy syndrome	1.08e-05	6.18e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Gabapentin—epilepsy syndrome	1.08e-05	6.16e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Gabapentin—epilepsy syndrome	1.08e-05	6.16e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Valproic Acid—epilepsy syndrome	1.07e-05	6.15e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Topiramate—epilepsy syndrome	1.07e-05	6.11e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Topiramate—epilepsy syndrome	1.06e-05	6.06e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Topiramate—epilepsy syndrome	1.05e-05	6.02e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Topiramate—epilepsy syndrome	1.04e-05	5.96e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Valproic Acid—epilepsy syndrome	1.04e-05	5.95e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Topiramate—epilepsy syndrome	1.04e-05	5.94e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Gabapentin—epilepsy syndrome	1.04e-05	5.94e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Topiramate—epilepsy syndrome	1.04e-05	5.93e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Topiramate—epilepsy syndrome	1.03e-05	5.92e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.03e-05	5.89e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Topiramate—epilepsy syndrome	1.03e-05	5.89e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Topiramate—epilepsy syndrome	1.02e-05	5.86e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Pregabalin—epilepsy syndrome	1.01e-05	5.79e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Topiramate—epilepsy syndrome	1.01e-05	5.78e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Valproic Acid—epilepsy syndrome	1e-05	5.75e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Gabapentin—epilepsy syndrome	9.99e-06	5.72e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Gabapentin—epilepsy syndrome	9.94e-06	5.7e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Gabapentin—epilepsy syndrome	9.94e-06	5.7e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Topiramate—epilepsy syndrome	9.89e-06	5.66e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Pregabalin—epilepsy syndrome	9.84e-06	5.64e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Pregabalin—epilepsy syndrome	9.7e-06	5.56e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Valproic Acid—epilepsy syndrome	9.64e-06	5.53e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.64e-06	5.52e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Topiramate—epilepsy syndrome	9.57e-06	5.48e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Valproic Acid—epilepsy syndrome	9.56e-06	5.48e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Valproic Acid—epilepsy syndrome	9.55e-06	5.47e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Valproic Acid—epilepsy syndrome	9.5e-06	5.44e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Topiramate—epilepsy syndrome	9.5e-06	5.44e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Topiramate—epilepsy syndrome	9.43e-06	5.4e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Topiramate—epilepsy syndrome	9.4e-06	5.39e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Pregabalin—epilepsy syndrome	9.38e-06	5.38e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Topiramate—epilepsy syndrome	9.31e-06	5.34e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Gabapentin—epilepsy syndrome	9.26e-06	5.31e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Topiramate—epilepsy syndrome	9.2e-06	5.27e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.13e-06	5.23e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Pregabalin—epilepsy syndrome	9.07e-06	5.2e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Topiramate—epilepsy syndrome	9.05e-06	5.18e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Topiramate—epilepsy syndrome	9.05e-06	5.18e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Gabapentin—epilepsy syndrome	9.02e-06	5.17e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Valproic Acid—epilepsy syndrome	9.01e-06	5.16e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Gabapentin—epilepsy syndrome	8.9e-06	5.1e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Pregabalin—epilepsy syndrome	8.72e-06	5e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Topiramate—epilepsy syndrome	8.72e-06	5e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.65e-06	4.96e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Pregabalin—epilepsy syndrome	8.65e-06	4.95e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Pregabalin—epilepsy syndrome	8.64e-06	4.95e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Gabapentin—epilepsy syndrome	8.6e-06	4.93e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Pregabalin—epilepsy syndrome	8.59e-06	4.92e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Topiramate—epilepsy syndrome	8.4e-06	4.82e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Topiramate—epilepsy syndrome	8.36e-06	4.79e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Topiramate—epilepsy syndrome	8.36e-06	4.79e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Gabapentin—epilepsy syndrome	8.31e-06	4.76e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Pregabalin—epilepsy syndrome	8.15e-06	4.67e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Gabapentin—epilepsy syndrome	7.99e-06	4.58e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Gabapentin—epilepsy syndrome	7.93e-06	4.54e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Gabapentin—epilepsy syndrome	7.92e-06	4.54e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Gabapentin—epilepsy syndrome	7.88e-06	4.51e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Topiramate—epilepsy syndrome	7.79e-06	4.47e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Topiramate—epilepsy syndrome	7.59e-06	4.35e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Topiramate—epilepsy syndrome	7.48e-06	4.29e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Gabapentin—epilepsy syndrome	7.47e-06	4.28e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Topiramate—epilepsy syndrome	7.24e-06	4.15e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Topiramate—epilepsy syndrome	7e-06	4.01e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Topiramate—epilepsy syndrome	6.73e-06	3.85e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Topiramate—epilepsy syndrome	6.67e-06	3.82e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Topiramate—epilepsy syndrome	6.66e-06	3.82e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Topiramate—epilepsy syndrome	6.63e-06	3.8e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Topiramate—epilepsy syndrome	6.28e-06	3.6e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Hemostasis—FYN—epilepsy syndrome	3.24e-06	4e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.24e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.24e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.24e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.24e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.24e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	3.23e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.22e-06	3.97e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	3.22e-06	3.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	3.16e-06	3.9e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	3.16e-06	3.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	3.15e-06	3.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	3.15e-06	3.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	3.14e-06	3.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	3.12e-06	3.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—YWHAZ—epilepsy syndrome	3.12e-06	3.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TXNRD1—epilepsy syndrome	3.1e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.08e-06	3.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	3.08e-06	3.8e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	3.07e-06	3.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.05e-06	3.77e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	3.04e-06	3.75e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AQP1—epilepsy syndrome	3.03e-06	3.73e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GPX1—epilepsy syndrome	3.03e-06	3.73e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—TH—epilepsy syndrome	3.03e-06	3.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ADSL—epilepsy syndrome	3.02e-06	3.72e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AQP1—epilepsy syndrome	3.01e-06	3.71e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.01e-06	3.71e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.01e-06	3.71e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3e-06	3.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3e-06	3.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	2.99e-06	3.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—BCHE—epilepsy syndrome	2.98e-06	3.68e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.98e-06	3.67e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GLUL—epilepsy syndrome	2.96e-06	3.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.96e-06	3.65e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AGT—epilepsy syndrome	2.94e-06	3.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	2.93e-06	3.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.91e-06	3.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	2.9e-06	3.58e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—AKT1—epilepsy syndrome	2.89e-06	3.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.89e-06	3.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.89e-06	3.56e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—APOE—epilepsy syndrome	2.88e-06	3.55e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	2.86e-06	3.52e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	2.84e-06	3.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.83e-06	3.49e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.81e-06	3.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PLCB1—epilepsy syndrome	2.81e-06	3.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—TH—epilepsy syndrome	2.8e-06	3.46e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PLAU—epilepsy syndrome	2.77e-06	3.41e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	2.76e-06	3.4e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	2.76e-06	3.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	2.74e-06	3.38e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	2.74e-06	3.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—KCNJ11—epilepsy syndrome	2.72e-06	3.36e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CHRM3—epilepsy syndrome	2.72e-06	3.36e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CAT—epilepsy syndrome	2.72e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CAT—epilepsy syndrome	2.72e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	2.72e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.7e-06	3.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.68e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.68e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.68e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.68e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.68e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.67e-06	3.3e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AGT—epilepsy syndrome	2.65e-06	3.27e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	2.64e-06	3.26e-05	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—AKT1—epilepsy syndrome	2.64e-06	3.26e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	2.64e-06	3.26e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AQP1—epilepsy syndrome	2.64e-06	3.25e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—APOE—epilepsy syndrome	2.6e-06	3.21e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	2.58e-06	3.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PRKCB—epilepsy syndrome	2.57e-06	3.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.55e-06	3.14e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NOS2—epilepsy syndrome	2.54e-06	3.14e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.53e-06	3.13e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	2.52e-06	3.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.51e-06	3.1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.5e-06	3.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.49e-06	3.08e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CAT—epilepsy syndrome	2.49e-06	3.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.48e-06	3.06e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—POMC—epilepsy syndrome	2.47e-06	3.05e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GPX1—epilepsy syndrome	2.46e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GPX1—epilepsy syndrome	2.46e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.45e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.45e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.45e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	2.42e-06	2.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.41e-06	2.97e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.38e-06	2.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.38e-06	2.94e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.36e-06	2.91e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—HMOX1—epilepsy syndrome	2.34e-06	2.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CAT—epilepsy syndrome	2.31e-06	2.85e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.28e-06	2.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.28e-06	2.81e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ALB—epilepsy syndrome	2.26e-06	2.78e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	2.25e-06	2.78e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.25e-06	2.78e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—epilepsy syndrome	2.25e-06	2.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—epilepsy syndrome	2.24e-06	2.77e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—POMC—epilepsy syndrome	2.23e-06	2.75e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.23e-06	2.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCG2—epilepsy syndrome	2.22e-06	2.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.17e-06	2.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.16e-06	2.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.16e-06	2.67e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AGT—epilepsy syndrome	2.16e-06	2.66e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AGT—epilepsy syndrome	2.16e-06	2.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.15e-06	2.65e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.15e-06	2.65e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.14e-06	2.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.14e-06	2.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.13e-06	2.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.13e-06	2.63e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—APOE—epilepsy syndrome	2.11e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—APOE—epilepsy syndrome	2.11e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GPX1—epilepsy syndrome	2.09e-06	2.57e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.09e-06	2.57e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.04e-06	2.51e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ALB—epilepsy syndrome	2.04e-06	2.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.03e-06	2.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.03e-06	2.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.01e-06	2.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TH—epilepsy syndrome	2.01e-06	2.48e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AGT—epilepsy syndrome	1.98e-06	2.44e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	2.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.96e-06	2.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.95e-06	2.41e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.94e-06	2.4e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.94e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.94e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.94e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—APOE—epilepsy syndrome	1.94e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.9e-06	2.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.89e-06	2.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.88e-06	2.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.86e-06	2.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.86e-06	2.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.85e-06	2.28e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.85e-06	2.28e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—BCHE—epilepsy syndrome	1.84e-06	2.27e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AGT—epilepsy syndrome	1.83e-06	2.26e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.82e-06	2.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.82e-06	2.25e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—POMC—epilepsy syndrome	1.81e-06	2.24e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—POMC—epilepsy syndrome	1.81e-06	2.24e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.79e-06	2.21e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—APOE—epilepsy syndrome	1.79e-06	2.21e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.79e-06	2.21e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	1.78e-06	2.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.76e-06	2.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.75e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.74e-06	2.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TH—epilepsy syndrome	1.74e-06	2.14e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PLCB1—epilepsy syndrome	1.73e-06	2.14e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TH—epilepsy syndrome	1.73e-06	2.13e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.71e-06	2.11e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.7e-06	2.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.7e-06	2.1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.68e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.67e-06	2.06e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—POMC—epilepsy syndrome	1.66e-06	2.05e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ALB—epilepsy syndrome	1.65e-06	2.04e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ALB—epilepsy syndrome	1.65e-06	2.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.65e-06	2.04e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—epilepsy syndrome	1.64e-06	2.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.62e-06	2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.62e-06	2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.62e-06	2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.61e-06	1.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.61e-06	1.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—POMC—epilepsy syndrome	1.54e-06	1.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.54e-06	1.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.52e-06	1.87e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ALB—epilepsy syndrome	1.52e-06	1.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TH—epilepsy syndrome	1.51e-06	1.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SRC—epilepsy syndrome	1.51e-06	1.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.49e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.47e-06	1.82e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.47e-06	1.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.47e-06	1.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.45e-06	1.79e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	1.45e-06	1.79e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	1.45e-06	1.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HMOX1—epilepsy syndrome	1.44e-06	1.78e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.43e-06	1.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CAT—epilepsy syndrome	1.42e-06	1.76e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALB—epilepsy syndrome	1.4e-06	1.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.39e-06	1.72e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—epilepsy syndrome	1.38e-06	1.71e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.33e-06	1.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.31e-06	1.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.29e-06	1.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GPX1—epilepsy syndrome	1.29e-06	1.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.28e-06	1.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.26e-06	1.56e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CAT—epilepsy syndrome	1.25e-06	1.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	1.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.2e-06	1.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.17e-06	1.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.16e-06	1.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.14e-06	1.4e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AGT—epilepsy syndrome	1.13e-06	1.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.13e-06	1.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.11e-06	1.37e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—APOE—epilepsy syndrome	1.11e-06	1.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.1e-06	1.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.05e-06	1.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.01e-06	1.24e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	9.97e-07	1.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	9.92e-07	1.22e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	9.92e-07	1.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AGT—epilepsy syndrome	9.89e-07	1.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—APOE—epilepsy syndrome	9.69e-07	1.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—POMC—epilepsy syndrome	9.56e-07	1.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—POMC—epilepsy syndrome	9.5e-07	1.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.47e-07	1.17e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—epilepsy syndrome	9.39e-07	1.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.36e-07	1.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TH—epilepsy syndrome	9.33e-07	1.15e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—epilepsy syndrome	8.95e-07	1.1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	8.8e-07	1.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALB—epilepsy syndrome	8.71e-07	1.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—POMC—epilepsy syndrome	8.32e-07	1.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.79e-07	9.61e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.68e-07	9.48e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	7.62e-07	9.4e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALB—epilepsy syndrome	7.59e-07	9.36e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—epilepsy syndrome	7.58e-07	9.35e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.47e-07	9.22e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—epilepsy syndrome	7.27e-07	8.97e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—epilepsy syndrome	7.27e-07	8.97e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.95e-07	8.57e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	6.67e-07	8.22e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.64e-07	8.19e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—epilepsy syndrome	6.17e-07	7.61e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.09e-07	7.52e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.97e-07	7.36e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.13e-07	6.33e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.68e-07	5.77e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.42e-07	5.46e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.09e-07	5.05e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.83e-07	4.73e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—epilepsy syndrome	3.81e-07	4.7e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.34e-07	4.12e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.06e-07	2.54e-06	CbGpPWpGaD
